Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1347493rdf:typepubmed:Citationlld:pubmed
pubmed-article:1347493lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:1347493lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:1347493lifeskim:mentionsumls-concept:C0242629lld:lifeskim
pubmed-article:1347493lifeskim:mentionsumls-concept:C0040149lld:lifeskim
pubmed-article:1347493lifeskim:mentionsumls-concept:C0677607lld:lifeskim
pubmed-article:1347493lifeskim:mentionsumls-concept:C0085247lld:lifeskim
pubmed-article:1347493lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:1347493lifeskim:mentionsumls-concept:C0205160lld:lifeskim
pubmed-article:1347493lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:1347493lifeskim:mentionsumls-concept:C0483191lld:lifeskim
pubmed-article:1347493lifeskim:mentionsumls-concept:C0547047lld:lifeskim
pubmed-article:1347493pubmed:issue3lld:pubmed
pubmed-article:1347493pubmed:dateCreated1992-4-13lld:pubmed
pubmed-article:1347493pubmed:abstractTextWe examined peripheral lymphocyte subsets in patients with autoimmune thyroid disease, or subacute thyroiditis, in the active stage when possible. During destructive thyrotoxicosis arising from alpha beta T cell receptor (TCR) negative T (WT31-CD3+) cells and CD8 (CD4-CD8+) cells decreased and those of CD4+CD8+ cells increased slightly, resulting in proportional increases in CD4 (CD4+CD8-) cells, non-T, non-B (CD5-CD19-) cells, and the CD4/CD8 cell ratio. Changes were similar in active subacute thyroiditis. During stimulative thyrotoxicosis in active Graves' disease, the numbers of such T lymphocyte subsets were not changed, but only the number of CD5+ B (CD5+CD19+) cells increased markedly, resulting in proportional decreases in total T (CD3+) cells, alpha beta+ TCR T (WT31+CD3+) cells, CD8 cells, and non-T, non-B cells. A serial study of some of the patients showed opposite changes in alpha beta TCR- T cells, the CD4/CD8 cell ratio, and CD5+ B cells between the active stages of Graves' and Hashimoto's diseases. alpha beta TCR- T cells were mostly gamma delta TCR+ T (IIF2+ CD3+) cells in these patients. These data suggest that alpha beta TCR-T (gamma delta TCR+ T), CD8, and CD4+ CD8+ cells are important in thyroid destruction in Hashimoto's disease and subacute thyroiditis, and that CD5+ B cells are important in thyroid stimulation in Graves' disease.lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:languageenglld:pubmed
pubmed-article:1347493pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:citationSubsetIMlld:pubmed
pubmed-article:1347493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347493pubmed:statusMEDLINElld:pubmed
pubmed-article:1347493pubmed:monthMarlld:pubmed
pubmed-article:1347493pubmed:issn0009-9104lld:pubmed
pubmed-article:1347493pubmed:authorpubmed-author:TamakiHHlld:pubmed
pubmed-article:1347493pubmed:authorpubmed-author:IchiharaKKlld:pubmed
pubmed-article:1347493pubmed:authorpubmed-author:MiyaiKKlld:pubmed
pubmed-article:1347493pubmed:authorpubmed-author:AminoNNlld:pubmed
pubmed-article:1347493pubmed:authorpubmed-author:KumaKKlld:pubmed
pubmed-article:1347493pubmed:authorpubmed-author:KanedaTTlld:pubmed
pubmed-article:1347493pubmed:authorpubmed-author:MatsuzukaFFlld:pubmed
pubmed-article:1347493pubmed:authorpubmed-author:HidakaYYlld:pubmed
pubmed-article:1347493pubmed:authorpubmed-author:IwataniYYlld:pubmed
pubmed-article:1347493pubmed:authorpubmed-author:FukataSSlld:pubmed
pubmed-article:1347493pubmed:issnTypePrintlld:pubmed
pubmed-article:1347493pubmed:volume87lld:pubmed
pubmed-article:1347493pubmed:ownerNLMlld:pubmed
pubmed-article:1347493pubmed:authorsCompleteYlld:pubmed
pubmed-article:1347493pubmed:pagination444-9lld:pubmed
pubmed-article:1347493pubmed:dateRevised2010-9-7lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:meshHeadingpubmed-meshheading:1347493-...lld:pubmed
pubmed-article:1347493pubmed:year1992lld:pubmed
pubmed-article:1347493pubmed:articleTitleDecreases in alpha beta T cell receptor negative T cells and CD8 cells, and an increase in CD4+ CD8+ cells in active Hashimoto's disease and subacute thyroiditis.lld:pubmed
pubmed-article:1347493pubmed:affiliationDepartment of Laboratory Medicine, Osaka University Medical School, Japan.lld:pubmed
pubmed-article:1347493pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1347493pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1347493pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed